• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间皮瘤的局部自发消退——可能的免疫机制

Localised spontaneous regression in mesothelioma -- possible immunological mechanism.

作者信息

Robinson B W, Robinson C, Lake R A

机构信息

University Department of Medicine, University of Western Australia, Sir Charles Gairdner Hospital, G Block, 4th Floor, Monash Avenue, 6009, Nedlands, Australia.

出版信息

Lung Cancer. 2001 May;32(2):197-201. doi: 10.1016/s0169-5002(00)00217-8.

DOI:10.1016/s0169-5002(00)00217-8
PMID:11325491
Abstract

Malignant mesothelioma (MM) is an aggressive tumor usually associated with asbestos exposure. Although it can remain stable for prolonged periods, it has not been described to spontaneously regress. MM tumors are thought to be immunogenic based both on animal studies and on the good responses in some humans treated with immunotherapy. Here we present a case of pleural MM in which a transient spontaneous regression was associated with tumor tissue infiltration with mononuclear cells and serological evidence of anti-MM reactivity. The patient's tumor eventually progressed and with this progression there was evidence of loss of serological reactivity to some, but not all, of her MM antigens. The patient survived for 20 months and, in contrast to her initial biopsy, no significant lymphoid infiltrate was detected in her MM tissue at post mortem examination.

摘要

恶性间皮瘤(MM)是一种侵袭性肿瘤,通常与接触石棉有关。尽管它可以长期保持稳定,但尚未有自发消退的报道。基于动物研究以及一些接受免疫治疗的患者的良好反应,MM肿瘤被认为具有免疫原性。在此,我们报告一例胸膜MM病例,其中短暂的自发消退与肿瘤组织单核细胞浸润以及抗MM反应性的血清学证据相关。患者的肿瘤最终进展,随着进展,有证据表明其对部分(而非全部)MM抗原的血清学反应性丧失。患者存活了20个月,与最初的活检结果相反,尸检时在其MM组织中未检测到明显的淋巴细胞浸润。

相似文献

1
Localised spontaneous regression in mesothelioma -- possible immunological mechanism.间皮瘤的局部自发消退——可能的免疫机制
Lung Cancer. 2001 May;32(2):197-201. doi: 10.1016/s0169-5002(00)00217-8.
2
[Asbestos fibre lung burden and exposure indices in asbestos-cement workers].[石棉水泥工人的石棉纤维肺负荷与暴露指数]
Med Lav. 2009 Jan-Feb;100(1):21-8.
3
Pleural mesothelioma in a woman whose documented past exposure to asbestos was from smoking asbestos-containing filtered cigarettes: the comparative value of analytical transmission electron microscopic analysis of lung and lymph-node tissue.一名有记录表明过去接触石棉是由于吸含石棉过滤嘴香烟的女性患胸膜间皮瘤:肺和淋巴结组织的分析型透射电子显微镜分析的比较价值
Inhal Toxicol. 2006 Aug;18(9):679-84. doi: 10.1080/08958370600743068.
4
Asbestos-related diseases in entertainment workers.娱乐工作者与石棉相关的疾病。
Med Lav. 2010 Nov-Dec;101(6):416-8.
5
Asbestos burden in two cases of mesothelioma where the work history included manufacturing of cigarette filters.两例间皮瘤患者的石棉负荷情况,其工作经历包括香烟过滤嘴制造。
J Toxicol Environ Health A. 2002 Aug 23;65(16):1109-20. doi: 10.1080/152873902760125354.
6
Crocidolite and mesothelioma.青石棉与间皮瘤。
Ultrastruct Pathol. 2008 Sep-Oct;32(5):171-7. doi: 10.1080/01913120802343848.
7
[Role of surgery in the treatment of pleural mesothelioma].[手术在胸膜间皮瘤治疗中的作用]
Chir Ital. 1989 Aug-Dec;41(4-6):192-206.
8
[Radiologic diagnosis in malignant pleural mesothelioma].[恶性胸膜间皮瘤的放射学诊断]
Radiol Med. 1984 Nov;70(11):830-6.
9
Mesothelioma and analysis of tissue fiber content.间皮瘤与组织纤维含量分析
Recent Results Cancer Res. 2011;189:79-95. doi: 10.1007/978-3-642-10862-4_6.
10
Desmoplastic malignant mesothelioma of the pleura: autopsy reveals asbestos exposure.胸膜促纤维增生性恶性间皮瘤:尸检显示有石棉接触史。
Pathol Int. 2003 Jun;53(6):401-6. doi: 10.1046/j.1440-1827.2003.01488.x.

引用本文的文献

1
How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies.我们对间皮瘤临床前近交系小鼠模型的持续研究如何影响新疗法的开发。
Front Pharmacol. 2022 Mar 31;13:858557. doi: 10.3389/fphar.2022.858557. eCollection 2022.
2
Immunotherapy in malignant pleural mesothelioma: a review of literature data.恶性胸膜间皮瘤的免疫治疗:文献数据综述
Transl Lung Cancer Res. 2021 Jun;10(6):2988-3000. doi: 10.21037/tlcr-20-673.
3
Biological basis for novel mesothelioma therapies.
新型间皮瘤治疗方法的生物学基础。
Br J Cancer. 2021 Oct;125(8):1039-1055. doi: 10.1038/s41416-021-01462-2. Epub 2021 Jul 5.
4
Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma.胸腔液中干扰素-γ作为恶性胸膜间皮瘤生存预后因素的评估。
Cancer Immunol Immunother. 2021 Nov;70(11):3349-3355. doi: 10.1007/s00262-021-02965-w. Epub 2021 May 18.
5
Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors-Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment.免疫检查点抑制剂的表观遗传改变与生物标志物——恶性胸膜间皮瘤治疗的当前标准与未来展望
Front Oncol. 2020 Dec 14;10:554570. doi: 10.3389/fonc.2020.554570. eCollection 2020.
6
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future.恶性胸膜间皮瘤:当前治疗方法的最新进展及未来展望
Front Oncol. 2020 Jan 24;9:1519. doi: 10.3389/fonc.2019.01519. eCollection 2019.
7
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma.肿瘤浸润淋巴细胞和 PD-L1 表达作为恶性胸膜间皮瘤患者预后的潜在预测指标。
Mol Biol Rep. 2019 Jun;46(3):2713-2720. doi: 10.1007/s11033-019-04715-9. Epub 2019 Mar 6.
8
A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma - the SKOPOS trial.一项单中心II期试验,旨在评估TroVax®联合培美曲塞/顺铂对恶性胸膜间皮瘤患者的免疫活性——SKOPOS试验。
Oncoimmunology. 2018 Sep 7;7(12):e1457597. doi: 10.1080/2162402X.2018.1457597. eCollection 2018.
9
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.胸膜间皮瘤中复杂染色体重排的新抗原潜力。
J Thorac Oncol. 2019 Feb;14(2):276-287. doi: 10.1016/j.jtho.2018.10.001. Epub 2018 Oct 10.
10
Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts-a case report.恶性胸膜间皮瘤患者在接受白树提取物和黑嚏根草提取物治疗后出现轻微病情缓解及长期生存(56个月)——病例报告
J Thorac Dis. 2017 Dec;9(12):E1064-E1070. doi: 10.21037/jtd.2017.11.56.